Tusc3-flox Mouse
一般名
Tusc3-flox
製品ID
S-CKO-16932
背景情報
C57BL/6NCya
系統ID
CKOCMP-80286-Tusc3-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Tusc3-flox Mouse(カタログ番号S-CKO-16932)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Tusc3-flox
系統ID
CKOCMP-80286-Tusc3-B6N-VA
遺伝子名
製品ID
S-CKO-16932
遺伝子別名
N33
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conditional knockout
染色体
Chr 8
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000239508
NCBIトランスクリプトID
NM_030254
ターゲット領域
Exon 2
有効領域の大きさ
~0.6 kb
遺伝子研究の概要
TUSC3, short for Tumor Suppressor Candidate 3, is a gene located on chromosome 8p22. It encodes a 34 kD protein which is a subunit of the oligosaccharyl transferase responsible for the N-glycosylation of nascent proteins in the endoplasmic reticulum [1]. It is also involved in magnesium transport and homeostasis as an Mg2+-transporter, which is crucial for learning and memory, embryonic development, and testis maturation [1]. Dysregulation of TUSC3 has been linked to various diseases, especially cancer, highlighting its biological importance. Genetic models, such as gene knockout models, can be valuable for studying its functions.
In cervical squamous cell carcinoma, down-regulation of TUSC3 promoted cell metastasis via the AKT signalling pathway, suggesting it may serve as a prognostic marker and potential target [2]. In hepatocellular carcinoma, decreased TUSC3 expression led to enhanced cell proliferation and migration, and it regulated epithelial-mesenchymal transition (EMT) through the LIPC/AKT axis [3]. In colorectal cancer, TUSC3 was found to promote the formation of cellular stemness and induce drug resistance via the Hedgehog signalling pathway [4]. Also, its promoter methylation in peripheral blood cells shows promise as a biomarker for CRC diagnosis [5]. In clear cell renal cell carcinoma, TUSC3 expression was downregulated, and it may inhibit the progression of the disease, potentially serving as a tumor marker for early diagnosis and prognosis [6]. In glioblastoma, epigenetic reactivation of TUSC3 can reprogram sensitivity to temozolomide regardless of MGMT promoter methylation status [7].
In conclusion, TUSC3 is essential for protein N-glycosylation and magnesium homeostasis. Through gene knockout or other loss-of-function models in various cancers, it has been revealed that TUSC3 plays significant roles in cancer cell proliferation, invasion, metastasis, drug resistance, and EMT. Understanding TUSC3 functions can provide new insights into cancer mechanisms and potential therapeutic targets. Additionally, its potential as a biomarker in cancer diagnosis and as a therapeutic target in XMEN disease further emphasizes its importance in biomedical research.
References:
1. Yu, Xinshuang, Zhai, Chunjuan, Fan, Yujun, Wang, Jia, Du, Juan. 2017. TUSC3: a novel tumour suppressor gene and its functional implications. In Journal of cellular and molecular medicine, 21, 1711-1718. doi:10.1111/jcmm.13128. https://pubmed.ncbi.nlm.nih.gov/28272772/
2. Sun, Fei, Jie, Qiuling, Li, Qi, Yue, Xiaojing, Ma, Yanlin. 2022. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway. In Journal of cellular and molecular medicine, 26, 1629-1642. doi:10.1111/jcmm.17204. https://pubmed.ncbi.nlm.nih.gov/35137520/
3. Deng, Ruxia, Lu, Xiansheng, Hong, Chang, Chen, Qiaoyu, Lin, Jie. 2022. Downregulation of TUSC3 promotes EMT and hepatocellular carcinoma progression through LIPC/AKT axis. In Journal of translational medicine, 20, 485. doi:10.1186/s12967-022-03690-3. https://pubmed.ncbi.nlm.nih.gov/36274132/
4. Ren, Yansong, Deng, Ruxia, Cai, Rui, Ding, Yanqing, Lin, Jie. . TUSC3 induces drug resistance and cellular stemness via Hedgehog signaling pathway in colorectal cancer. In Carcinogenesis, 41, 1755-1766. doi:10.1093/carcin/bgaa038. https://pubmed.ncbi.nlm.nih.gov/32338281/
5. Siri, Goli, Mosallaei, Meysam, Ehtesham, Naeim, Nasrollahzadeh Sabet, Mehrdad, Behroozi, Javad. 2023. TUSC3 Methylation in Peripheral Blood Cells as a Biomarker for Diagnosis of Colorectal Cancer. In Advanced biomedical research, 12, 174. doi:10.4103/abr.abr_396_22. https://pubmed.ncbi.nlm.nih.gov/37564442/
6. Yan, Youji, Chen, Zhongjun, Liao, Yixiang, Zhou, Jiajie. 2019. TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma. In Oncology letters, 17, 5073-5079. doi:10.3892/ol.2019.10161. https://pubmed.ncbi.nlm.nih.gov/31186719/
7. Wu, Qiong, Berglund, Anders E, Macaulay, Robert J, Etame, Arnold B. 2023. Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status. In International journal of molecular sciences, 24, . doi:10.3390/ijms242015179. https://pubmed.ncbi.nlm.nih.gov/37894860/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
